ESTA · NASDAQ
Establishment Labs Holdings Inc.
$70.40 +1.23 (+1.77%)
Company overview
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2, gravity-sensitive round soft silicone-gel-filled breast implants; and the Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes the Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and a direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $2.1B
- Employees
- 1,034
- Headquarters
- Alajuela
- Website
- establishmentlabs.com
- CEO
- Fillipo Peter Caldini
- Listed
- July 19, 2018
- P/E
- -47.88
- Dividend yield
- 0.00%
Company financials
- Revenue
- $230M
- Gross profit
- $161M
- Operating income
- -$28.6M
- EBITDA
- -$20.4M
- Net income
- -$43.7M
- EPS
- -$1.48
- Total assets
- $351M
- Total debt
- $264M
- Gross margin
- 70.06%
- Net margin
- -19.05%
- Earnings yield
- -2.09%
No product segmentation.
Showing FY 2025
ESTA
1D
NASDAQ
O65.92H69.96L65.92C69.18+2.22 (+3.32%)Vol205.25K